CAS No.: 250159-48-9
Miriplatin (hydrate) Catalog No. CSN18156
Synonyms: SM-11355 (hydrate);Miriplatin;SM-11355
Miriplatin is approved for lipiodolization for the treatment of hepatocellular carcinoma and it is a lipophilic platinum complex containing myristates as leaving groups, and can be easily suspended in ethyl esters of iodized fatty acids obtained from poppy seed oil.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 参考文献
- [1] Kishimoto S, Noguchi T, et al. In vitro cytotoxicity of cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)] platinum(II) suspended in lipiodol in rat hepatoma AH-109A cells and human tumor cell lines. Biol Pharm Bull. 2000 Apr;23(4):487-91.
- [2] Kishimoto S, Miyazawa K, et al. In vitro antitumor activity, intracellular accumulation, and DNA adduct formation of cis-[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)] platinum (II) suspended in lipiodol. Jpn J Cancer Res. 2000 Jan;91(1):99-104.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 250159-48-9 | 储存条件 |
|
|
| 分子式 | C34H70N2O5Pt | 运输 | 蓝冰 | |
| 分子量 | 782.01 | 别名 | SM-11355 (hydrate);Miriplatin;SM-11355;Miripla;Miriplatin hydrate;MTP;SM-11355 (hydrate |
